 | Up a level |
Brown, DM; Kaiser, PK; Michels, M; Soubrane, G; Heier, JS; Kim, RY; Sy, JP; Schneider, S; ANCHOR, Study Group (2006). Ranibizumab versus verteporfin for neovascular age-related macular degeneration. New England journal of medicine NEJM, 355(14), pp. 1432-44. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa062655
